AI-based company focused on early detection of neurodegenerative diseases through a simple eye exam

RetiSpec is an AI-based company focused on early detection of neurodegenerative diseases through a simple eye exam. RetiSpec’s proprietary AI solution leverages existing retinal imaging cameras to provide a non-invasive, accurate and scalable solution for the early detection of Alzheimer’s disease. RetiSpec is backed by strong partners and investors, including iGan Partners, Verge HealthTech Fund, Alzheimer’s Drug Discovery Foundation, Gentex Medical, Global Alzheimer’s Platform Foundation and Topcon Healthcare.